重组人脑利钠肽治疗难治性心力衰竭的临床研究

被引：12

作者：

王天巨

任玮

机构：

[1] 内蒙古乌海市人民医院心内科

来源：

中国心血管杂志 | 2011年 / 16卷 / 01期

关键词：

利钠肽,脑; 心力衰竭,充血性; 每搏输出量;

D O I：

暂无

中图分类号：

R541.6 [血液循环衰竭];

学科分类号：

1002 ; 100201 ;

摘要：

目的研究重组人脑利钠肽(rhBNP)治疗难治性心力衰竭(RHF)的临床疗效。方法选择心功能分级(NYHA)Ⅲ～Ⅳ级的RHF患者60例,分为rhBNP组(rhBNP治疗)和对照组(硝普钠治疗)各30例,观察两组患者治疗前后生命体征、相关心功能指标和氨基末端脑钠肽前体(NT-proBNP)浓度的变化。所有患者均知情同意。结果 (1)与治疗前比较,rhBNP组治疗后左心室射血分数(LVEF)升高(38.5%±7.3%比28.4%±6.0%),24 h尿量增多[(920.0±320.0)ml比(500.0±120.0)ml],心率[(91.0±6.5)次/min比(112.0±1.3)次/min]、血肌酐[(86.0±17.2)μmol/L比(101.6±18.5)μmol/L]下降,差异均有统计学意义(均为P<0.05);(2)两组治疗后,rh-BNP组LVEF高于对照组(31.7%±8.9%),24 h尿量多于对照组[(740.0±140.0)ml],心率低于对照组[(107.0±7.7)次/min],肌酐低于对照组[(101.4±15.6)μmol/L],差异均有统计学意义(均为P<0.05);(3)两组治疗前后,NT-proBNP、收缩压(SBP)和左心室舒张末期内径(LVDd)差异均无统计学意义(P>0.05)。结论 rhBNP可明显改善RHF患者的心功能,其近期效果优于硝普钠治疗。

引用

页码：19 / 22

页数：4

共 9 条

[1] 重组人脑利钠肽治疗难治性心力衰竭18例疗效分析 [J].

郑向清 ;

梅霞 ;

吴文莉 ;

罗羽慧 ;

李正恭 ;

张源 .

重庆医学, 2009, 38 (12) :1508-1509

[2] 重组人脑利钠肽和硝酸甘油治疗急性失代偿性心力衰竭疗效和安全性的随机、开放、平行对照的多中心临床研究 [J].

谢洪智 ;

朱文玲 .

中华心血管病杂志, 2006, (03) :222-226

[3]

Prevalence and Prognostic Significance of Heart Failure Stages: Application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in the Community[J] . Khawaja Afzal Ammar,Steven J. Jacobsen,Douglas W. Mahoney,Jan A. Kors,Margaret M. Redfield,John C. Burnett,Richard J. Rodeheffer.Circulation . 2007 (12)

[4]

Treatment with B-Type Natriuretic Peptide for Chronic Decompensated Heart Failure: Insights Learned from the Follow-Up Serial Infusion of Nesiritide （FUSION） Trial[J] . Clyde W. Yancy.Heart Failure Reviews . 2005 (3)

[5] Recent advances in natriuretic peptides in congestive heart failure [J].

Boerrigter, G ;

Burnett, JC .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (06) :643-652

[6] Nesiritide for the treatment of decompensated heart failure [J].

Colucci, WS .

JOURNAL OF CARDIAC FAILURE, 2001, 7 (01) :92-100

[7] Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects [J].

Brunner-La Rocca, HP ;

Kaye, DM ;

Woods, RL ;

Hastings, J ;

Esler, MD .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 37 (05) :1221-1227

[8]

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure[J] . William T. Abraham,Brian D. Lowes,Deborah A. Ferguson,John Odom,Jin K. Kim,Alastair D. Robertson,Michael R. Bristow,Robert W. Schrier.Journal of Cardiac Failure . 1998 (1)

[9]

Myocardial Disease: Hemodynamic and Renal Excretory Effects of Human Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure: A Double-Blind, Placebo-Controlled, Randomized Crossover Trial[J] . Lee S. Marcus,Douglas Hart,Milton Packer,Madeline Yushak,Norma Medina,Robert S. Danziger,Daniel F. Heitjan,Stuart D. Katz.Circulation . 1996 (12)

← 1 →